Ameritas Investment Partners, Inc. Eli Lilly & CO Transaction History

Ameritas Investment Partners, Inc.

$2.98 Billion
Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 20,887 shares of LLY stock, worth $16.6 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

20,887

Previous 23,000 9.19%

Holding current value

$16.6 Million

Previous $20.8 Million 11.14%

% of portfolio

0.62%

Previous 0.73%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $1.63 Million - $2.03 Million	-2,113 Reduced 9.19%	20,887 $18.5 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $499,435 - $626,328	-689 Reduced 2.91%	23,000 $20.8 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $396,181 - $530,035	-669 Reduced 2.75%	23,689 $18.4 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $663,840 - $782,580	-1,264 Reduced 4.93%	24,358 $14.2 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $916,347 - $1.26 Million	-2,108 Reduced 7.6%	25,622 $13.8 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $1.02 Million - $1.36 Million	-2,900 Reduced 9.47%	27,730 $13 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $65,232 - $76,612	210 Added 0.69%	30,630 $10.5 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $567,535 - $661,292	-1,765 Reduced 5.48%	30,420 $11.1 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $234,219 - $266,917	-790 Reduced 2.4%	32,185 $10.4 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $232,460 - $272,943	-834 Reduced 2.47%	32,975 $10.7 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $79,559 - $98,872	-339 Reduced 0.99%	33,809 $9.68 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $140,081 - $173,841	-623 Reduced 1.79%	34,148 $9.43 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $85,980 - $105,811	388 Added 1.13%	34,771 $8.03 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $176,939 - $228,869	-980 Reduced 2.77%	34,383 $7.89 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $93,498 - $121,037	-569 Reduced 1.58%	35,363 $6.31 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $223,738 - $296,060	-1,715 Reduced 4.56%	35,932 $6.07 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $196,373 - $227,141	-1,343 Reduced 3.44%	37,647 $5.57 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $730,938 - $879,676	-5,358 Reduced 12.08%	38,990 $6.4 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $68,572 - $84,873	-576 Reduced 1.28%	44,348 $6.15 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $245,167 - $303,661	-2,293 Reduced 4.86%	44,924 $5.9 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $18,261 - $19,863	-171 Reduced 0.36%	47,217 $5.28 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $26,257 - $30,648	-237 Reduced 0.5%	47,388 $5.25 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $281,948 - $331,873	-2,533 Reduced 5.05%	47,625 $6.18 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $351,270 - $393,528	3,317 Added 7.08%	50,158 $5.8 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $76,501 - $95,613	-891 Reduced 1.87%	46,841 $5.03 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $157,834 - $181,144	-2,085 Reduced 4.19%	47,732 $4.07 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $420,696 - $496,604	-5,669 Reduced 10.22%	49,817 $3.85 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $1,474 - $1,582	-18 Reduced 0.03%	55,486 $4.92 Million
Q3 2017 Nov 15, 2017	SELL	$77.07 - $85.54 $135,720 - $150,635	-1,761 Reduced 3.08%	55,504 $4.65 Million
Q2 2017 Aug 15, 2017	BUY	N/A	57,265	57,265 $4.71 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Eli Lilly & CO Transaction History